Evidence map›Paper›PMID 41122818›Full record

ArticleJournal of proteome research2025

Evaluation of a Prototype Orbitrap Astral Zoom Mass Spectrometer for Quantitative Proteomics─Beyond Identification Lists.

Chris Hsu, Nicholas Shulman, Hamish I Stewart, Johannes Petzoldt, Anna Pashkova, Deanna L Plubell, Eduard Denisov, Bernd Hagedorn, Nicolaie E Damoc, Brendan X MacLean and 7 more

Abstract readEvaluation Study
In one paragraph

Article in Journal of proteome research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Atlas of lysine acetylation in the mouse.bioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Chris HsuDepartment of Genome Sciences, University of Washington, 3720 15th Street NE, Seattle, Washington 98195, United States.ORCID 0000-0002-0846-6126
Nicholas ShulmanDepartment of Genome Sciences, University of Washington, 3720 15th Street NE, Seattle, Washington 98195, United States.ORCID 0000-0003-1674-0794
Hamish I StewartThermo Fisher Scientific, Hanna-Kunath Str. 11, Bremen 28199, Germany.ORCID 0009-0000-1510-4353
Johannes PetzoldtThermo Fisher Scientific, Hanna-Kunath Str. 11, Bremen 28199, Germany.
Anna PashkovaThermo Fisher Scientific, Hanna-Kunath Str. 11, Bremen 28199, Germany.
Deanna L PlubellDepartment of Genome Sciences, University of Washington, 3720 15th Street NE, Seattle, Washington 98195, United States.ORCID 0000-0002-6580-8073
Eduard DenisovThermo Fisher Scientific, Hanna-Kunath Str. 11, Bremen 28199, Germany.
Bernd HagedornThermo Fisher Scientific, Hanna-Kunath Str. 11, Bremen 28199, Germany.
Nicolaie E DamocThermo Fisher Scientific, Hanna-Kunath Str. 11, Bremen 28199, Germany.
Brendan X MacLeanDepartment of Genome Sciences, University of Washington, 3720 15th Street NE, Seattle, Washington 98195, United States.ORCID 0000-0002-9575-0255
Philip M RemesThermo Fisher Scientific, 355 River Oaks Parkway, San Jose, California 95134, United States.
Jesse D CanterburyThermo Fisher Scientific, 355 River Oaks Parkway, San Jose, California 95134, United States.
Alexander A MakarovThermo Fisher Scientific, Hanna-Kunath Str. 11, Bremen 28199, Germany.ORCID 0000-0002-7046-6709
Christian HockThermo Fisher Scientific, Hanna-Kunath Str. 11, Bremen 28199, Germany.
Vlad ZabrouskovThermo Fisher Scientific, 355 River Oaks Parkway, San Jose, California 95134, United States.ORCID 0000-0003-3567-9407
Christine C WuDepartment of Genome Sciences, University of Washington, 3720 15th Street NE, Seattle, Washington 98195, United States.
Michael J MacCossDepartment of Genome Sciences, University of Washington, 3720 15th Street NE, Seattle, Washington 98195, United States.ORCID 0000-0003-1853-0256

Funding

Project 4: Novel reagent development to enable molecular characterizationU19AG065156 · NIA · UNIVERSITY OF WASHINGTON · PI HOOFNAGLE, ANDREW N · 2020 to 2024
$15.9M
Neurobehavior, Neuropathology, and Risk Factors in Alzheimer's DiseaseT32AG052354 · NIA · UNIVERSITY OF WASHINGTON · PI Brian C. Kraemer, ELAINE R. PESKIND · 2016 to 2026
$6.7M
Seattle Quant: A Resource for the Skyline Software EcosystemR24GM141156 · NIGMS · UNIVERSITY OF WASHINGTON · PI Michael MacCoss · 2021 to 2026
$6.7M
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetesU01DK137097 · NIDDK · UNIVERSITY OF WASHINGTON · PI ANDREW N HOOFNAGLE, Michael MacCoss · 2023 to 2026
$3.4M
NIA NIH HHS T32 AG052354NIA NIH HHS U19 AG065156NIDDK NIH HHS U01 DK137097NIGMS NIH HHS R24 GM141156
6 · The paper itself

Abstract

Mass spectrometry instrumentation continues to evolve rapidly, yet quantifying these advances beyond conventional peptide and protein detections remains challenging. Here, we evaluate a modified Orbitrap Astral Zoom mass spectrometer (MS) prototype and compare its performance to the standard Orbitrap Astral MS. Across a range of acquisition methods and sample inputs, the prototype instrument outperformed the standard Orbitrap Astral MS in precursor and protein identifications, ion beam utilization, and quantitative precision. To enable meaningful cross-platform comparisons, we implemented an ion calibration framework that converts signal intensity from arbitrary units to ions per second. This benchmarking strategy showed that the prototype sampled 23.1% more ions per peptide than the original Orbitrap Astral MS. This increase in the ion beam utilization resulted in improved sensitivity and quantitative precision. To make these metrics broadly accessible, we added new metrics to the Skyline document grid to report the number of ions measured in a spectrum at the apex of the elution peak or the sum of ions between the peak integration boundaries. Taken together, our results demonstrate the Orbitrap Astral Zoom prototype as a high-performance platform for data-independent acquisition proteomics and establish a generalizable framework for evaluation of MS performance based on the number of ions detected for each analyte. Data are available on Panorama Public and ProteomeXchange under the identifier PXD064536.

Indexed as

Mass SpectrometryProteomicsHumansPeptidesPeptidesDIAinstrument comparisonsion calibrationliquid chromatographymass spectrometryOrbitrap Astral Zoomproteomicsquantitative results

Identifiers

PMID41122818
PMCPMC12604027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.